Latest News

Young Epilepsy welcomes NICE’s approval of CBD as treatment for children with epilepsy

Responding to the publication of the NICE guidelines on cannabis-based medicinal products and the approval of CBD as a treatment, Mark Devlin, Chief Executive of Young Epilepsy, said: Living with epilepsy can have a significant impact on the lives of children, young people and their families.

Source link

Related posts

Opinion: Lost opportunities from FDA, NIH inaction when sponsors fail to report clinical trial results


Access to mobile phone location data can help understand spread of vector-borne diseases


Nearly half of female hydroxychloroquine users in UK excess-dosed


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World